Search research articles
Contact Us
Filters
Showing results (81-90 of 134) with videos related to
Page
of 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening
Shengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
Cancer Research Communications
|
March 26, 2026
Pre-Clinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report
Nikolina Radulovich, Pamela Soberanis Pina, Molly L Udaskin, et al.
Journal of Gynecologic Oncology
|
December 22, 2024
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)
Jung-Yun Lee, David Tan, Isabelle Ray-Coquard, et al.
Nature Communications
|
May 13, 2026
Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial
Ana C Veneziani, Stephanie Lheureux, Douglas G Millar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2025
Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With Cancer
Javaid Iqbal, Rahim Moineddin, Kieran L Quinn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 20, 2019
<i>TP53</i> mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
Victoria Mandilaras, Swati Garg, Michael Cabanero, et al.
Nature Reviews. Cancer
|
May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Flurina A M Saner, Alan Herschtal, Brad H Nelson, et al.
Obstetrics and Gynecology International
|
June 12, 2018
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective
Yeh Chen Lee, Nazlin Jivraj, Catherine O'Brien, et al.
Cell Reports
|
August 28, 2025
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab
Shirin Soleimani, Xuan Li, Ben X Wang, et al.
Translational Oncology
|
August 24, 2025
Elucidating divergent biology in uterine carcinosarcoma
Vikas Garg, Stephenie D Prokopec, Simone C Stone, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 134) with videos related to
Sort By:
Page
of 14
Proceedings of the National Academy of Sciences of the United States of America
|
June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening
Shengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
Cancer Research Communications
|
March 26, 2026
Pre-Clinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report
Nikolina Radulovich, Pamela Soberanis Pina, Molly L Udaskin, et al.
Journal of Gynecologic Oncology
|
December 22, 2024
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)
Jung-Yun Lee, David Tan, Isabelle Ray-Coquard, et al.
Nature Communications
|
May 13, 2026
Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial
Ana C Veneziani, Stephanie Lheureux, Douglas G Millar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2025
Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With Cancer
Javaid Iqbal, Rahim Moineddin, Kieran L Quinn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 20, 2019
<i>TP53</i> mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
Victoria Mandilaras, Swati Garg, Michael Cabanero, et al.
Nature Reviews. Cancer
|
May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Flurina A M Saner, Alan Herschtal, Brad H Nelson, et al.
Obstetrics and Gynecology International
|
June 12, 2018
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective
Yeh Chen Lee, Nazlin Jivraj, Catherine O'Brien, et al.
Cell Reports
|
August 28, 2025
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab
Shirin Soleimani, Xuan Li, Ben X Wang, et al.
Translational Oncology
|
August 24, 2025
Elucidating divergent biology in uterine carcinosarcoma
Vikas Garg, Stephenie D Prokopec, Simone C Stone, et al.
Page
of 14